Cite
HARVARD Citation
Bose, N. et al. (n.d.). Anti-beta glucan antibodies represent a mechanism-based biomarker to select patients responsive to the novel immunotherapeutic, Imprime PGG. European journal of cancer. pp. S106-S107. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bose, N. et al. (n.d.). Anti-beta glucan antibodies represent a mechanism-based biomarker to select patients responsive to the novel immunotherapeutic, Imprime PGG. European journal of cancer. pp. S106-S107. [Online].